Abstract
The hazard assessment of skin sensitizers relies mainly on animal testing, but much progress is made in the development, validation and regulatory acceptance and implementation of non-animal predictive approaches. In this review, we provide an update on the available computational tools and animal-free test methods for the prediction of skin sensitization hazard. These individual test methods address mostly one mechanistic step of the process of skin sensitization induction. The adverse outcome pathway (AOP) for skin sensitization describes the key events (KEs) that lead to skin sensitization. In our review, we have clustered the available test methods according to the KE they inform: the molecular initiating event (MIE/KE1)—protein binding, KE2—keratinocyte activation, KE3—dendritic cell activation and KE4—T cell activation and proliferation. In recent years, most progress has been made in the development and validation of in vitro assays that address KE2 and KE3. No standardized in vitro assays for T cell activation are available; thus, KE4 cannot be measured in vitro. Three non-animal test methods, addressing either the MIE, KE2 or KE3, are accepted as OECD test guidelines, and this has accelerated the development of integrated or defined approaches for testing and assessment (e.g. testing strategies). The majority of these approaches are mechanism-based, since they combine results from multiple test methods and/or computational tools that address different KEs of the AOP to estimate skin sensitization potential and sometimes potency. Other approaches are based on statistical tools. Until now, eleven different testing strategies have been published, the majority using the same individual information sources. Our review shows that some of the defined approaches to testing and assessment are able to accurately predict skin sensitization hazard, sometimes even more accurate than the currently used animal test. A few defined approaches are developed to provide an estimate of the potency sub-category of a skin sensitizer as well, but these approaches need further independent evaluation with a new dataset of chemicals. To conclude, this update shows that the field of non-animal approaches for skin sensitization has evolved greatly in recent years and that it is possible to predict skin sensitization hazard without animal testing.
Similar content being viewed by others
References
Adler S, Basketter D, Creton S et al (2011) Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010. Arch Toxicol 85(5):367–485
Albrekt A-S, Johansson H, Börje A, Borrebaeck C, Lindstedt M (2014) Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency. BMC Pharmacol Toxicol 15(1):1–13
Alépée N, Piroird C, Aujoulat M et al (2015) Prospective multicentre study of the U-SENS test method for skin sensitization testing. Toxicol in Vitro 30((1, Part B)):373–382
Alves VM, Muratov E, Fourches D et al (2015) Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization. Toxicol Appl Pharm 284(2):273–280
Api AM, Basketter DA, Cadby PA et al (2008) Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regul Toxicol Pharmacol 52(1):3–23
Aptula AO, Roberts DW (2006) Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity. Chem Res Toxicol 19(8):1097–1105
Ashikaga T, Sakaguchi H, Sono S et al (2010) A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern Lab Anim 38(4):275–284
Avonto C, Chittiboyina AG, Rua D, Khan IA (2015) A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers. Toxicol Appl Pharmacol 289(2):177–184
Barratt MD, Basketter DA, Chamberlain M, Admans GD, Langowski JJ (1994a) An expert system rulebase for identifying contact allergens. Toxicol In Vitro 8(5):1053–1060
Barratt MD, Basketter DA, Chamberlain M, Payne MP, Admans GD, Langowski JJ (1994b) Development of an expert system rulebase for identifying contact allergens. Toxicol In Vitro 8(4):837–839
Basketter DA, Andersen KE, Liden C et al (2005) Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. Contact Dermat 52(1):39–43
Basketter D, Pease C, Kasting G et al (2007) Skin sensitisation and epidermal disposition: the relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM workshop 59. Altern Lab Anim 35(1):137–154
Basketter D, Ashikaga T, Casati S et al (2015) Alternatives for skin sensitisation: hazard identification and potency categorisation: Report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015. Regul Toxicol Pharmacol 73(2):660–666
Bauch C, Kolle SN, Fabian E et al (2011) Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals. Toxicol In Vitro 25(6):1162–1168
Bauch C, Kolle SN, Ramirez T et al (2012) Putting the parts together: combining in vitro methods to test for skin sensitizing potentials. Regul Toxicol Pharmacol 63(3):489–504
Casati S, Aeby P, Basketter DA et al (2005) Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern Lab Anim 33(1):47–62
Chaudhry Q, Piclin N, Cotterill J et al (2010) Global QSAR models of skin sensitisers for regulatory purposes. Chem Cent J 4(Suppl 1):S5
Coleman KP, McNamara LR, Grailer TP et al (2015) Evaluation of an in vitro human dermal sensitization test for use with medical device extracts. Appl In Vitro Toxicol 1(2):13
Corsini E, Mitjans M, Galbiati V, Lucchi L, Galli CL, Marinovich M (2009) Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol In Vitro 23(5):789–796
Corsini E, Galbiati V, Mitjans M, Galli CL, Marinovich M (2013) NCTC 2544 and IL-18 production: a tool for the identification of contact allergens. Toxicology In Vitro 27(3):1127–1134
Cottrez F, Boitel E, Auriault C, Aeby P, Groux H (2015) Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay. Toxicol In Vitro 29(4):787–802
Cottrez F, Boitel E, Ourlin J-C et al (2016) SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: reproducibility and predictivity results from an inter-laboratory study. Toxicol In Vitro 32:248–260
Dancik Y, Miller MA, Jaworska J, Kasting GB (2013) Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure. Adv Drug Deliv Rev 65(2):221–236
Davies M, Pendlington RU, Page L et al (2011) Determining epidermal disposition kinetics for use in an integrated nonanimal approach to skin sensitization risk assessment. Toxicol Sci 119(2):308–318
Dietz L, Kinzebach S, Ohnesorge S et al (2013) Proteomic allergen–peptide/protein interaction assay for the identification of human skin sensitizers. Toxicol In Vitro 27(3):1157–1162
Dimitrov SD, Low LK, Patlewicz GY et al (2005) Skin sensitization: modeling based on skin metabolism simulation and formation of protein conjugates. Int J Toxicol 24(4):189–204
Dos Santos GG, Spiekstra SW, Sampat-Sardjoepersad SC, Reinders J, Scheper RJ, Gibbs S (2011) A potential in vitro epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro 25(1):347–357
Dumont C, Prieto P, Asturiol D, Worth A (2015) Review of the availability of in vitro and in silico methods for assessing dermal bioavailability. Appl In Vitro Toxicol 1(2):147–164
Dumont C, Barroso J, Matys I, Worth A, Casati S (2016) Analysis of the Local Lymph Node Assay (LLNA) variability for assessing the prediction of skin sensitisation potential and potency of chemicals with non-animal approaches. Toxicol In Vitro 34:220–228
Enoch SJ, Madden JC, Cronin MT (2008) Identification of mechanisms of toxic action for skin sensitisation using a SMARTS pattern based approach. SAR QSAR Environ Res 19(5–6):555–578
Enslein K, Gombar VK, Blake BW et al (1997) A quantitative structure-toxicity relationships model for the dermal sensitization guinea pig maximization assay. Food Chem Toxicol 35(10–11):1091–1098
EURL-ECVAM (2013a) EURL ECVAM recommendation on the Direct Peptide Reactivity Assay (DRPA) for skin sensitisation testing European Commission Joint Research Centre. Institute for Health and Consumer Protection. European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM)
EURL-ECVAM (2013b) EURL ECVAM recommendation on the Keratinosens™ assay for skin sensitisation testing European Commission Joint Research Centre. Institute for Health and Consumer Protection. European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM)
EURL-ECVAM (2014) EURL ECVAM recommendation on the Keratinosens™ assay for skin sensitisation testing. European Commission Joint Research Centre. Institute for Health and Consumer Protection. European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM)
EURL-ECVAM (2015a) EURL ECVAM Recommendation on the human Cell Line Activation Test (h-CLAT) for skin sensitisation testing. European Commission, Joint Research Centre, Institute for Health and Consumer Protection
EURL-ECVAM (2015b) EURL ECVAM Status Report on the Development, Validation and Regulatory Acceptance of Alternative Methods and Approaches. European Commission, Joint Research Centre, Institute for Health and Consumer Protection
EURL-ECVAM (2015c) EURL ECVAM status report on the development, validation and regulatory acceptance of alternative methods and approaches (2015) European Commission, Joint Research Centre, Institute for Health and Consumer Protection
Frombach J, Sonnenburg A, Krapohl B-D, Zuberbier T, Stahlmann R, Schreiner M (2016) A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics. Arch Toxicol. doi:10.1007/s00204-016-1722-y
Galbiati V, Mitjans M, Lucchi L et al (2011) Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. Toxicol In Vitro 25(3):724–732
Galvão dos Santos G, Reinders J, Ouwehand K, Rustemeyer T, Scheper RJ, Gibbs S (2009) Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol Appl Pharmacol 236(3):372–382
Gealy R, Graham C, Sussman NB, Macina OT, Rosenkranz HS, Karol MH (1996) Evaluating clinical case report data for SAR modeling of allergic contact dermatitis. Hum Exp Toxicol 15(6):489–493
Gerberick GF, Vassallo JD, Bailey RE, Chaney JG, Morrall SW, Lepoittevin JP (2004) Development of a peptide reactivity assay for screening contact allergens. Toxicol Sci 81(2):332–343
Gerberick GF, Vassallo JD, Foertsch LM, Price BB, Chaney JG, Lepoittevin JP (2007) Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol Sci 97(2):417–427
Gerberick GF, Troutman JA, Foertsch LM et al (2009) Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol Sci 112(1):164–174
Gibbs S, Corsini E, Spiekstra SW et al (2013) An epidermal equivalent assay for identification and ranking potency of contact sensitizers. Toxicol Appl Pharmacol 272(2):529–541
Griem P, Goebel C, Scheffler H (2003) Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data. Regul Toxicol Pharmacol 38(3):269–290
Hartung T, Luechtefeld T, Maertens A, Kleensang A (2013) Integrated testing strategies for safety assessments. ALTEX 30(1):3–18
Hirota M, Suzuki M, Hagino S et al (2009) Modification of cell-surface thiols elicits activation of human monocytic cell line THP-1: possible involvement in effect of haptens 2,4-dinitrochlorobenzene and nickel sulfate. J Toxicol Sci 34(2):139–150
Hoffmann S (2015) LLNA variability: an essential ingredient for a comprehensive assessment of non-animal skin sensitization test methods and strategies. ALTEX 32(4):379–383
Hooyberghs J, Schoeters E, Lambrechts N et al (2008) A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol Appl Pharmacol 231(1):103–111
Ibrahim R, Nitsche JM, Kasting GB (2012) Dermal clearance model for epidermal bioavailability calculations. J Pharm Sci 101(6):2094–2108
Jaworska J, Hoffmann S (2010) Integrated Testing Strategy (ITS)—opportunities to better use existing data and guide future testing in toxicology. ALTEX 27(4):231–242
Jaworska J, Harol A, Kern PS, Gerberick F (2011) Integrating non-animal test information into an adaptive testing strategy—skin sensitization proof of concept case. ALTEX 28(3):211–225
Jaworska J, Dancik Y, Kern P, Gerberick F, Natsch A (2013) Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice. J Appl Toxicol 33(11):1353–1364
Jaworska JS, Natsch A, Ryan C, Strickland J, Ashikaga T, Miyazawa M (2015) Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy. Arch Toxicol 89(12):2355–2383
Johansson H, Lindstedt M, Albrekt AS, Borrebaeck CA (2011) A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. BMC Genomics 12:399
Johansson H, Albrekt AS, Borrebaeck CA, Lindstedt M (2012) The GARD assay for assessment of chemical skin sensitizers. Toxicol In Vitro 27(3):1163–1169
Johansson H, Rydnert F, Kuhnl J, Schepky A, Borrebaeck C, Lindstedt M (2014) Genomic allergen rapid detection in-house validation—a proof of concept. Toxicol Sci 139(2):362–370
Johnson R, Macina OT, Graham C, Rosenkranz HS, Cass GR, Karol MH (1997) Prioritizing testing of organic compounds detected as gas phase air pollutants: structure-activity study for human contact allergens. Environ Health Perspect 105(9):986–992
Kagatani S, Sasaki Y, Hirota M et al (2010) Oxidation of cell surface thiol groups by contact sensitizers triggers the maturation of dendritic cells. J Invest Dermatol 130(1):175–183
Karlberg AT, Bergstrom MA, Borje A, Luthman K, Nilsson JL (2008) Allergic contact dermatitis—formation, structural requirements, and reactivity of skin sensitizers. Chem Res Toxicol 21(1):53–69
Kimber I, Basketter DA, Gerberick GF, Ryan CA, Dearman RJ (2011) Chemical allergy: translating biology into hazard characterization. Toxicol Sci 120(suppl 1):S238–S268
Klopman G, Ivanov J, Saiakhov R, Chakravarti S (2005) MC4PC—an artificial intelligence approach to the discovery of structure toxic activity relationships (STAR). In: Helma C (ed) Predictive Toxicology. CRC Press, Boca Raton, FL, pp 423–457
Lambrechts N, Vanheel H, Hooyberghs J et al (2010a) Gene markers in dendritic cells unravel pieces of the skin sensitization puzzle. Toxicol Lett 196(2):95–103
Lambrechts N, Vanheel H, Nelissen I et al (2010b) Assessment of chemical skin sensitizing potency by an in vitro assay based on human dendritic cells. Toxicol Sci 116(1):122–129
Lambrechts N, Nelissen I, Van Tendeloo V et al (2011) Functionality and specificity of gene markers for skin sensitization in dendritic cells. Toxicol Lett 203(2):106–110
Langton K, Patlewicz GY, Long A, Marchant CA, Basketter DA (2006) Structure-activity relationships for skin sensitization: recent improvements to Derek for Windows. Contact Dermat 55(6):342–347
Luechtefeld T, Maertens A, McKim JM, Hartung T, Kleensang A, Sá-Rocha V (2015) Probabilistic hazard assessment for skin sensitization potency by dose–response modeling using feature elimination instead of quantitative structure–activity relationships. J Appl Toxicol 35(11):1361–1371
MacKay C, Davies M, Summerfield V, Maxwell G (2013) From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment. ALTEX 30(4):473–486
Macmillan DS, Canipa SJ, Chilton ML, Williams RV, Barber CG (2016) Predicting skin sensitisation using a decision tree integrated testing strategy with an in silico model and in chemico/in vitro assays. Regul Toxicol Pharmacol 76:30–38
Martin SF, Esser PR, Schmucker S et al (2010) T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Sci 67(24):4171–4184
Martin SF, Esser PR, Weber FC et al (2011) Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66(9):1152–1163
Maxwell G, MacKay C, Cubberley R et al (2014) Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment. Toxicol In Vitro 28(1):8–12
McKim JM, Keller DJ, Gorski JR (2010) A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan Ocul Toxicol 29(3):171–192
McKim JM, Jr., Keller DJ, Gorski JR (2012) An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing. Cutan Ocul Toxicol 31(4):292–305
Mitragotri S, Anissimov YG, Bunge AL et al (2011) Mathematical models of skin permeability: an overview. Int J Pharm 418(1):115–129
Natsch A (2010) The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers—functional relevance and a hypothesis on innate reactions to skin sensitizers. Toxicol Sci 113(2):284–292
Natsch A, Gfeller H (2008) LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol Sci 106(2):464–478
Natsch A, Bauch C, Foertsch L et al (2011) The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories. Toxicol In Vitro 25(3):733–744
Natsch A, Ryan CA, Foertsch L et al (2013) A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J Appl Toxicol JAT 33(11):1337–1352
Natsch A, Emter R, Gfeller H, Haupt T, Ellis G (2015) Predicting skin sensitizer potency based on in vitro data from keratinosens and kinetic peptide binding: global versus domain-based assessment. Toxicol Sci 143(2):319–332
Nukada Y, Ashikaga T, Sakaguchi H et al (2011) Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT). Contact Dermat 65(6):343–353
Nukada Y, Miyazawa M, Kazutoshi S, Sakaguchi H, Nishiyama N (2013) Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals. Toxicol In Vitro 27(2):609–618
OECD (1992) OECD Guidelines for the testing of chemicals, section 4: health effects, Test No. 406 skin sensitization. OECD Publishing, Paris
OECD (2007) Guidance on grouping of chemicals OECD environmental health and safety publications, series on testing and assessment no 80. OECD Publishing, Paris
OECD (2008) Workshop on integrated approaches to testing and assessment. In: Publishing O (ed) Series on testing and assessment no 88. OECD Publishing, Paris
OECD (2010a) Guidelines for the testing of chemicals. Section 4: health effects. Test No. 429. Skin sensitization: local lymph node assay. OECD Publishing, Paris
OECD (2010b) Guidelines for the testing of chemicals. Section 4: health effects. Test no. 442A skin sensitization: local lymph node assay: DA. OECD Publishing, Paris
OECD (2010c) OECD guidelines for the testing of chemicals. Section 4: health effects. Test no. 442B skin sensitization: local lymph node assay: BrdU-ELISA. OECD Publishing, Paris
OECD (2012) The adverse outcome pathway for skin sensitisation initiated by covalent binding for proteins. Part 1. Scientific evidence OECD environment, health and safety publications series on testing and assessment, vol 168. OECD Publishing, Paris, pp 1–46
OECD (2014) Guidance on grouping of chemicals, 2nd Ed. Environment, health 22 and safety publications, series on testing and assessment no. 194 23 series on testing and assessment, vol ENV/JM/MONO(2014)4. OECD Publishing, Paris
OECD (2015a) OECD guidelines for the testing of chemicals, Section 4. Test No. 442C: in chemico skin sensitisation: Direct Peptide Reactivity Assay (DPRA). OECD Publishing, Paris
OECD (2015b) OECD guidelines for the testing of chemicals, Section 4. Test No. 442D: in vitro skin sensitisation: ARE-Nrf2 Luciferase test method. OECD Publishing, Paris
OECD (2015c) Test No. 442D: in vitro skin sensitisation: ARE-Nrf2 Luciferase test method. OECD Publishing, Paris
OECD (2016a) Guidance document on the reporting of defined approaches and individual information sources to be used within Integrated Approaches to Testing and Assessment (IATA) for skin sensitisation In: OECD Environment HaSP (ed) Series on testing and assessment, vol ENV/JM/HA(2016)11. OECD Publishing, Paris
OECD (2016b) Guidance document on the reporting of defined approaches to be used within integrated approaches to testing and assessment In: OECD Environment HaSP (ed) Series on testing and assessment, vol ENV/JM/HA(2016)10. OECD Publishing, Paris
OECD (2016c) OECD Guidelines for the Testing of Chemicals, Section 4. Test No. 442E: in vitro skin sensitisation: human Cell Line Activation Test (h-CLAT) vol ENV/JM/WRPR(2016)19]. OECD Publishing, Paris
Patlewicz G, Kuseva C, Kesova A et al (2014) Towards AOP application–implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization. Regul Toxicol Pharmacol 69(3):529–545
Pendlington RU, Minter HJ, Stupart L et al (2008) Development of a modified in vitro skin absorption method to study the epidermal/dermal disposition of a contact allergen in human skin. Cutan Ocul Toxicol 27(4):283–294
Piroird C, Ovigne J-M, Rousset F et al (2015) The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization. Toxicol In Vitro 29(5):901–916
Pirone JR, Smith M, Kleinstreuer NC et al (2014) Open source software implementation of an integrated testing strategy for skin sensitization potency based on a Bayesian network. ALTEX 31(3):336–340
Ramirez T, Mehling A, Kolle SN et al (2014) LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification. Toxicol In Vitro 28(8):1482–1497
Ramirez T, Stein N, Aumann A et al (2016) Intra- and inter-laboratory reproducibility and accuracy of the LuSens assay: a reporter gene-cell line to detect keratinocyte activation by skin sensitizers. Toxicol In Vitro 32:278–286
Reuter H, Gerlach S, Spieker J et al (2015) Evaluation of an optimized protocol using human peripheral blood monocyte derived dendritic cells for the in vitro detection of sensitizers: results of a ring study in five laboratories. TiV 29(5):976–986
Richter A, Schmucker SS, Esser PR et al (2013) Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC—IFN-γ and TNF-α readout. Toxicol In Vitro 27(3):1180–1185
Roberts DW, Aptula AO, Patlewicz G, Pease C (2008) Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential. J Appl Toxicol 28(4):443–454
Rorije E, Aldenberg T, Buist H, Kroese D, Schuurmann G (2013) The OSIRIS weight of evidence approach: ITS for skin sensitisation. Regul Toxicol Pharmacol 67(2):146–156
Rovida C, Alepee N, Api AM et al (2015) Integrated testing strategies (ITS) for safety assessment. ALTEX 32(1):25–40
Saito K, Nukada Y, Takenouchi O, Miyazawa M, Sakaguchi H, Nishiyama N (2013) Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis. Toxicol In Vitro 27(8):2213–2224
Sakaguchi H, Ashikaga T, Miyazawa M et al (2006) Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol In Vitro 5:774–784
Sakaguchi H, Ryan C, Ovigne JM, Schroeder KR, Ashikaga T (2010) Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. Toxicol In Vitro 24(6):1810–1820
Schneider K, Akkan Z (2004) Quantitative relationship between the local lymph node assay and human skin sensitization assays. Regul Toxicol Pharmacol 39(3):245–255
Schreiner M, Peiser M, Briechle D, Stahlmann R, Zuberbier T, Wanner R (2007) A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential. Allergy 62(12):1419–1428
Sonnenburg A, Schreiner M, Stahlmann R (2015) Assessment of the sensitizing potency of preservatives with chance of skin contact by the loose-fit coculture-based sensitization assay (LCSA). Arch Toxicol 89(12):2339–2344
Strickland J, Zang Q, Kleinstreuer N et al (2016) Integrated decision strategies for skin sensitization hazard. J Appl Toxicol. doi:10.1002/jat.3281
Suzuki M, Hirota M, Hagino S, Itagaki H, Aiba S (2009) Evaluation of changes of cell-surface thiols as a new biomarker for in vitro sensitization test. Toxicol In Vitro 23(4):687–696
Takahashi T, Kimura Y, Saito R et al (2011) An in vitro test to screen skin sensitizers using a stable THP-1-derived IL-8 reporter cell line, THP-G8. Toxicol Sci 124(2):359–369
Takenouchi O, Miyazawa M, Saito K, Ashikaga T, Sakaguchi H (2013) Predictive performance of the human Cell Line Activation Test (h-CLAT) for lipophilic chemicals with high octanol-water partition coefficients. J Toxicol Sci 38(4):599–609
Takenouchi O, Fukui S, Okamoto K et al (2015) Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals. J Appl Toxicol 35(11):1318–1332
Teubner W, Mehling A, Schuster PX et al (2013) Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance. Regul Toxicol Pharmacol 67(3):468–485
Teunis M, Corsini E, Smits M et al (2013) Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro 27(3):1135–1150
Tollefsen KE, Scholz S, Cronin MT et al (2014) Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA). Regul Toxicol Pharmacol 70(3):629–640
Tsujita-Inoue K, Hirota M, Ashikaga T, Atobe T, Kouzuki H, Aiba S (2014) Skin sensitization risk assessment model using artificial neural network analysis of data from multiple in vitro assays. Toxicol In Vitro 28(4):626–639
Urbisch D, Mehling A, Guth K et al (2015) Assessing skin sensitization hazard in mice and men using non-animal test methods. Regul Toxicol Pharmacol 71(2):337–351
Van der Veen JW, Vandebriel R, Van Loveren H, Ezendam J (2011) Keratinocytes, innate immunity and allergic contact dermatitis—opportunities for the development of in vitro assays to predict the sensitizing potential of chemicals. In: Ro YS (ed) Contact dermatitis. Available from: http://www.intechopen.com/books/contact-dermatitis/keratinocytes-innate-immunity-and-allergic-contact-dermatitis-opportunities-for-the-development-of-i
Van der Veen JW, Pronk TE, van Loveren H, Ezendam J (2013) Applicability of a keratinocyte gene signature to predict skin sensitizing potential. Toxicol In Vitro 27(1):314–322
Van der Veen JW, Rorije E, Emter R, Natsch A, van Loveren H, Ezendam J (2014a) Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals. Regul Toxicol Pharmacol 69(3):371–379
Van der Veen JW, Soeteman-Hernandez LG, Ezendam J, Stierum R, Kuper FC, van Loveren H (2014b) Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: analysis of existing data. Crit Rev Toxicol 44(7):590–599
Van Och FM, Van Loveren H, Van Wolfswinkel JC, Machielsen AJ, Vandebriel RJ (2005) Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line. Toxicology 210(2–3):95–109
Vandebriel RJ, van Loveren H (2010) Non-animal sensitization testing: state-of-the-art. Crit Rev Toxicol 40(5):389–404
Vocanson M, Achachi A, Mutez V et al (2014) Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25+ cells improves the in vitro detectin of weak allergen-specific T cells. In: Martin SF (ed) T Lymphocytes as tools in diagnostics and immunotoxicology. Springer, Basel
Yamamoto Y, Tahara H, Usami R et al (2015) A novel in chemico method to detect skin sensitizers in highly diluted reaction conditions. J Appl Toxicol 35(11):1348–1360
Acknowledgments
We highly appreciate the critical comments and suggestions of Prof. Dr. Aldert Piersma of the RIVM. This review was written within the context of a research project funded by ZonMw (Grant No. 114022001; Systems toxicology supported data infrastructure for human risk assessment). In addition, the Dutch Ministries of Economic Affairs and of Health, Welfare and Sports are acknowledged for supporting this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ezendam, J., Braakhuis, H.M. & Vandebriel, R.J. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies. Arch Toxicol 90, 2861–2883 (2016). https://doi.org/10.1007/s00204-016-1842-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-016-1842-4